{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:17:26Z","timestamp":1740107846840,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T00:00:00Z","timestamp":1512950400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Novartis Pharmaceuticals"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s10157-017-1520-8","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T04:42:42Z","timestamp":1512967362000},"page":"773-781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Arterial wall hypertrophy is ameliorated by \u03b12-adrenergic receptor antagonist or aliskiren in kidneys of angiotensinogen-knockout mice"],"prefix":"10.1007","volume":"22","author":[{"given":"Haruka","family":"Nakamori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3728-6412","authenticated-orcid":false,"given":"Shin-ichiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Yasuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Ishigami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhito","family":"Hirawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Toya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,11]]},"reference":[{"issue":"50","key":"1520_CR1","doi-asserted-by":"crossref","first-page":"31334","DOI":"10.1016\/S0021-9258(18)31697-1","volume":"269","author":"K Tanimoto","year":"1994","unstructured":"Tanimoto K, Sugiyama F, Goto Y, Ishida J, Takimoto E, Yagami K, et al. Angiotensinogen-deficient mice with hypotension. J Biol Chem. 1994;269(50):31334\u20137.","journal-title":"J Biol Chem"},{"issue":"3","key":"1520_CR2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1523-1755.1998.00801.x","volume":"53","author":"M Kihara","year":"1998","unstructured":"Kihara M, Umemura S, Sumida Y, Yokoyama N, Yabana M, Nyui N, et al. Genetic deficiency of angiotensinogen produces an impaired urine concentrating ability in mice. Kidney Int. 1998;53(3):548\u201355.","journal-title":"Kidney Int"},{"issue":"6","key":"1520_CR3","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1172\/JCI118366","volume":"96","author":"F Niimura","year":"1995","unstructured":"Niimura F, Labosky PA, Kakuchi J, Okubo S, Yoshida H, Oikawa T, et al. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest. 1995;96(6):2947\u201354.","journal-title":"J Clin Invest"},{"key":"1520_CR4","unstructured":"Kim J, Padanilam BJ. Renal nerves drive interstitial fibrogenesis in obstructive nephropathy. J Am Soc Nephrol."},{"issue":"3","key":"1520_CR5","doi-asserted-by":"crossref","first-page":"F641","DOI":"10.1152\/ajprenal.00254.2010","volume":"300","author":"H Zheng","year":"2011","unstructured":"Zheng H, Liu X, Rao US, Patel KP. Increased renal ENaC subunits and sodium retention in rats with chronic heart failure. Am J Physiol Renal Physiol. 2011;300(3):F641\u2013F9.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"1520_CR6","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/HYPERTENSIONAHA.108.116350","volume":"52","author":"D Westermann","year":"2008","unstructured":"Westermann D, Riad A, Lettau O, Roks A, Savvatis K, Becher PM, et al. Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure. Hypertension. 2008;52(6):1068\u201375.","journal-title":"Hypertension"},{"issue":"2","key":"1520_CR7","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1046\/j.1523-1755.2001.060002722.x","volume":"60","author":"S Inokuchi","year":"2001","unstructured":"Inokuchi S, Kimura K, Sugaya T, Inokuchi K, Murakami K, Sakai T. Hyperplastic vascular smooth muscle cells of the intrarenal arteries in angiotensin II type 1a receptor null mutant mice. Kidney Int. 2001;60(2):722\u201331.","journal-title":"Kidney Int"},{"issue":"2","key":"1520_CR8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1523-1755.2004.00410.x","volume":"65","author":"S Racasan","year":"2004","unstructured":"Racasan S, Hahnel B, van der Giezen DM, Blezer EL, Goldschmeding R, Braam B, et al. Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension. Kidney Int. 2004;65(2):575\u201381.","journal-title":"Kidney Int"},{"issue":"5","key":"1520_CR9","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.2353\/ajpath.2007.070471","volume":"171","author":"T Hashimoto","year":"2007","unstructured":"Hashimoto T, Kihara M, Imai N, Yoshida S, Shimoyamada H, Yasuzaki H, et al. Requirement of apelin\u2013apelin receptor system for oxidative stress-linked atherosclerosis. Am J Pathol. 2007;171(5):1705\u201312.","journal-title":"Am J Pathol"},{"issue":"1","key":"1520_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.ki.5000079","volume":"69","author":"JA Oliver","year":"2006","unstructured":"Oliver JA. Receptor-mediated actions of renin and prorenin. Kidney Int. 2006;69(1):13\u20135.","journal-title":"Kidney Int"},{"issue":"1","key":"1520_CR11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/HYPERTENSIONAHA.107.108845","volume":"52","author":"DL Feldman","year":"2008","unstructured":"Feldman DL, Jin L, Xuan H, Contrepas A, Zhou Y, Webb RL, et al. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats. Hypertension. 2008;52(1):130\u20136.","journal-title":"Hypertension"},{"issue":"5","key":"1520_CR12","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/ki.1997.190","volume":"51","author":"WA Border","year":"1997","unstructured":"Border WA, Noble NA. TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int. 1997;51(5):1388\u201396.","journal-title":"Kidney Int"},{"key":"1520_CR13","unstructured":"Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A. Targeted disruption of TGF-beta1\/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest."},{"key":"1520_CR14","unstructured":"Guan Q, Li S, Gao S, Chen H, Nguan CY, Du C. Reduction of chronic rejection of renal allografts by anti-transforming growth factor-beta antibody therapy in a rat model. Am J Physiol Renal Physiol."},{"issue":"18","key":"1520_CR15","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","volume":"342","author":"GC Blobe","year":"2000","unstructured":"Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med. 2000;342(18):1350\u20138.","journal-title":"N Engl J Med"},{"issue":"3","key":"1520_CR16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s10157-012-0721-4","volume":"17","author":"H Suzuki","year":"2013","unstructured":"Suzuki H, Okada K, Abe M, Maruyama N, Yoshida Y, Baba S, et al. Aliskiren reduces home blood pressure and albuminuria in patients with hypertensive nephrosclerosis. Clin Exp Nephrol. 2013;17(3):386\u201395.","journal-title":"Clin Exp Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-017-1520-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-017-1520-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-017-1520-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T04:37:59Z","timestamp":1660106279000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-017-1520-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,11]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1520"],"URL":"https:\/\/doi.org\/10.1007\/s10157-017-1520-8","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"type":"print","value":"1342-1751"},{"type":"electronic","value":"1437-7799"}],"subject":[],"published":{"date-parts":[[2017,12,11]]}}}